These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19022245)

  • 21. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion.
    Benlimame N; He Q; Jie S; Xiao D; Xu YJ; Loignon M; Schlaepfer DD; Alaoui-Jamali MA
    J Cell Biol; 2005 Nov; 171(3):505-16. PubMed ID: 16275754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.
    Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL
    J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
    Khoury H; Dankort DL; Sadekova S; Naujokas MA; Muller WJ; Park M
    Oncogene; 2001 Feb; 20(7):788-99. PubMed ID: 11314013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling.
    Eccles SA
    Recent Results Cancer Res; 2000; 157():41-54. PubMed ID: 10857161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways.
    Yu H; Gong X; Luo X; Han W; Hong G; Singh B; Tang CK
    Cancer Biol Ther; 2008 Nov; 7(11):1818-28. PubMed ID: 18787418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SePARating polarity and proliferation in ErbB2 oncogenesis.
    Walker SJ; Brugge JS
    Nat Cell Biol; 2006 Nov; 8(11):1220-2. PubMed ID: 17077856
    [No Abstract]   [Full Text] [Related]  

  • 28. SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells.
    Zhu XF; Wang JS; Cai LL; Zeng YX; Yang D
    Cancer Sci; 2006 Jan; 97(1):84-9. PubMed ID: 16367926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival.
    Grant S; Qiao L; Dent P
    Front Biosci; 2002 Feb; 7():d376-89. PubMed ID: 11815285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.
    Sidera K; Gaitanou M; Stellas D; Matsas R; Patsavoudi E
    J Biol Chem; 2008 Jan; 283(4):2031-41. PubMed ID: 18056992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal events: Cell signal transduction and its inhibition in cancer.
    Rowinsky EK
    Oncologist; 2003; 8 Suppl 3():5-17. PubMed ID: 14671224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ErbB receptor tyrosine family as signal integrators.
    Hynes NE; Horsch K; Olayioye MA; Badache A
    Endocr Relat Cancer; 2001 Sep; 8(3):151-9. PubMed ID: 11566606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma.
    O-charoenrat P; Rhys-Evans PH; Modjtahedi H; Eccles SA
    Oral Oncol; 2002 Oct; 38(7):627-40. PubMed ID: 12167415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis.
    Dow LE; Humbert PO
    Int Rev Cytol; 2007; 262():253-302. PubMed ID: 17631191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
    O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho1-Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila.
    Ma X; Chen Y; Zhang S; Xu W; Shao Y; Yang Y; Li W; Li M; Xue L
    Oncogene; 2016 Feb; 35(7):846-55. PubMed ID: 25961917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?
    Cordo Russo RI; Chervo MF; Madera S; Charreau EH; Elizalde PV
    Horm Cancer; 2019 Jun; 10(2-3):64-70. PubMed ID: 30656558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of erbB3 receptors in cancer therapeutic resistance.
    Lee Y; Ma J; Lyu H; Huang J; Kim A; Liu B
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):190-8. PubMed ID: 24449784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.